undamentalytics Newsletter

DuPont balance sheet

At the end of fiscal 2025, DuPont had total assets of $21.57bn, total liabilities of $7.47bn and shareholders' equity of $13.92bn. It held $715m in cash against $3.19bn of debt: net debt of $2.48bn.

Balance sheet

US$ billions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

DuPont: balance sheet, annual
Fiscal year2015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMSept 2026
Cash and equivalents8.66.613.48.51.52.52.03.72.41.80.71.7
Receivables—4.711.42.93.01.91.61.61.50.80.91.7
Inventory—7.416.94.14.32.42.12.32.11.11.21.2
Total current assets—23.750.1126.710.029.014.311.37.520.85.64.7
Goodwill12.215.334.834.522.116.017.016.77.77.67.97.8
Total assets67.979.5192.4187.969.370.945.741.438.636.621.620.8
Accounts payable———2.62.92.22.12.11.71.11.01.0
Deferred revenue (current)——2.10.10.00.00.00.00.00.0——
Total current liabilities—12.626.373.38.312.24.93.73.15.52.32.0
Short-term debt—0.31.90.03.80.00.20.30.01.80.10.0
Long-term debt—21.132.1−12.6−15.615.610.68.17.95.33.13.1
Total debt0.021.434.115.417.415.610.88.17.97.23.23.1
Total liabilities———92.027.831.818.714.313.812.87.57.1
Shareholders' equity26.226.0100.394.341.038.526.426.624.323.413.913.6
Net debt (negative = net cash)−8.614.820.66.915.913.18.84.55.55.42.51.4
Shares outstanding———784m739m734m——————

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: DD vs IEPDD vs MMMCODI vs DD

More: Industrial Conglomerates stocks compared, Industrials sector, rankings of US companies

Figures from DuPont's SEC filings (10-K and 10-Q), retrieved November 3, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to DuPont.